Yahoo奇摩 網頁搜尋

搜尋結果

1. www.arisglobal.com › uncategorized › webinar-pharmacovigilancePharmacovigilance in China – Current Updates, ...

   www.arisglobal.com › uncategorized › webinar-pharmacovigilance

   • 庫存頁面

   Uncategorized: Pharmacovigilance in China – Current Updates, Challenges and Solutions for the Industry. The Chinese Federal Drug Authority (CFDA) regulations are changing and that brings both challenges and opportunities. The introduction of the E2B (R3) mandate pushed the local Chinese pharmaceutical market to scramble.

2. www.arisglobal.com › regulatory-affairs-softwareRegulatory Affairs Software | LifeSphere Regulatory | ArisGlobal

   www.arisglobal.com › regulatory-affairs-software

   • 庫存頁面

   LifeSphere RIMS empowers your team to do more across the Regulatory lifecycle. It’s not just another technology, it’s a holistic solution for all of your Regulatory needs in Pharma, Device, and combination organizations. Regulatory Product Suite With LifeSphere® Publishing, you can compile, publish, and validate regulatory submissions with support for all major global eCTD requirements.

3. www.arisglobal.com › uncategorized › aginquireragInquirer | ArisGlobal

   www.arisglobal.com › uncategorized › aginquirer

   agInquirer. ArisGlobal is transforming the way today’s most successful Life Sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere ®, integrates our proprietary cognitive computing engine to automate all core functions of the drug development lifecycle ...

4. www.arisglobal.com › media › press-releaseDr. Reddy’s Laboratories Selects LifeSphere® ...

   www.arisglobal.com › media › press-release

   • 庫存頁面

   2021年1月21日 · The leading multination pharmaceutical company plans to use ArisGlobal’s platform to deliver the next generation of integrated signal detection and risk management globally. Miami, FL January 21, 2021 – Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY), an integrated global pharmaceutical company committed to providing affordable and innovative medicines for healthier ...

5. www.arisglobal.com › media › press-releaseLife Sciences Technology Leader ArisGlobal Invests Further ...

   www.arisglobal.com › media › press-release

   • 庫存頁面

   2023年3月9日 · The newly opened 47,000 square foot, sustainability-minded facility is home to cross-functional teams across the industry-leading SaaS company. Miami, United States, Bangalore, India, March 9, 2023 – ArisGlobal, the leading provider of life sciences software designed to automate core drug development with its platform LifeSphere® celebrates the recent opening of a flagship campus in Kalyani ...

6. www.arisglobal.com › media › press-releaseNew Generative AI Council to Advance Life Sciences ...

   www.arisglobal.com › media › press-release

   • 庫存頁面

   2024年2月1日 · Group announces inaugural session as well as its charter — to advance the use of GenAI in life sciences R&D Boston, Massachusetts, USA – February 1, 2024 – ArisGlobal, a leading innovative life sciences technology company and creator of LifeSphere®, today announced the formal charter for the new GenAI Council, which will sit for the first […]

7. www.arisglobal.com › uncategorized › whitepaper-lifesphereWhitepaper: LifeSphere Safety MultiVigilance (ARISg/ARISc) - ...

   www.arisglobal.com › uncategorized › whitepaper-lifesphere

   • 庫存頁面

   China is aligning its regulatory environment with that of global standards with an aim to promote innovation, simplify drug development processes and to enhance the efficacy, quality and safety of the drugs approved. Read this whitepaper to learn how LifeSphere Safety MultiVigilance (ARISc), the drug safety software